期刊文献+

肺泡蛋白沉积症9例临床病理特征与诊断

Clinicopathologic features and diagnosis of pulmonary alveolar proteinosis:a report of 9 cases
原文传递
导出
摘要 目的探讨肺泡蛋白沉积症(PAP)的临床病理特征及其诊断方法。方法对9例PAP进行常规HE染色,光镜观察,并用淀粉酶消化后过碘酸希夫(D-PAS)及黏液卡红进行组织化学染色。结果PAP显示肺泡腔内及部分小支气管腔内充满嗜伊红性细颗粒状蛋白性物质;蛋白性物质中杂有多少不等退变及脱落的肺泡上皮细胞;肺泡Ⅱ型上皮细胞增生;肺泡间隔毛细血管充血;周围肺组织代偿性肺气肿。此外,肺泡腔内嗜伊红性细颗粒状磷脂类蛋白性物质D-PAS(+)(呈紫红色),黏液卡红(-)。结论PAP临床罕见,易误诊或被忽视。典型PAP为肺泡腔内出现嗜伊红性细颗粒状蛋白性物质,蛋白性物质D-PAS(+),黏液卡红(-),是确诊PAP的主要方法。纤支镜及胸腔镜肺活检是获取标本的主要途径。 Objective To describe the clinicopathologic features and diagnostic algorithm of pulmonary alveolar proteinosis (PAP). Methods Nine biopsy cases of PAP were studied by hematoxylin-eosin(HE)stains and light microscopy, and histochemical staining using periodic acid-Schiff with digestion (D-PAS) and muciearmine. Results HE stained sections showed that the affected lung tissue displayed the following characteristic features: ( 1 ) alveoli and some of the small bronchioles were filled with eosinophilic and fine granular proteinaceons material; (2) proteinaceous material was admixed with various numbers of degenerated and sometimes exfoliated pneumoeytes; (3) pneumoeytes were hyperplastie; (4) alveolar capillaries and alveolar septa had become hyperemie; (5) compensating emphysema was noted in the surrounding lung parenchyma. Histochemical staining showed that the proteinaceous material was stained purple by D-PAS, and mucicarmine was negative. Conclusion PAP is a rare and it is easily misdiagnosed or neglected. Identification of homogeneous, eosinophilic, finely granular and D-PAS -positive proteinaceous material in alveolar spaces is of diagnostic importance in PAP. Fiber bronchoscopy and videoassised thoracoscopic lung biopsy is the main way to obtain the specimens.
出处 《诊断病理学杂志》 CSCD 2009年第6期437-439,共3页 Chinese Journal of Diagnostic Pathology
关键词 肺疾病 肺泡蛋白沉积症 临床病理特征 Lung diseases Pulmonary alveolar proteinosis Clinicopathologic features
  • 相关文献

参考文献8

二级参考文献36

  • 1徐凯峰,陈燕,郭子健,朱元珏.肺泡蛋白沉积症患者血清中抗粒-巨噬细胞集落刺激因子抗体等血清学指标的临床意义[J].中华结核和呼吸杂志,2004,27(12):824-828. 被引量:34
  • 2Seymour JF,Presneill JJ. Pulmonary alveolar proteinosis:progress in the first 44 years. Am J Respir Crit Care Med,2002,166:215-235.
  • 3Trapnell BC,Whitsett JA,Nakata K. Pulmonary alveolar proteinosis. N Engl J Med,2003,349:2527-2539.
  • 4Kitamura T,Uchida K,Tanaka N,et al. Serological diagnosis of idopathic pulmonary alveolar proteinosis. Am J Respir Crit Care Med,2000,162(2 Pt 1):658-662.
  • 5Bonfield TL,Russell D,Burgess S,et al. Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis. Am J Respir Cell Mol Biol,2002,27:481-486.
  • 6Carraway MS,Ghio AJ,Carter JD,et al. Detection of granulocyte-macrophage colony-stimulating factor in patients with pulmonary alveolar proteinosis. Am J Respir Crit Care Med,2000,161(4 Pt 1):1294-1299.
  • 7Bonfield TL,Russell D,Burgess S,et al. Hematopoietic colony stimulating factor in pulmonary alveolar proteinosis(PAP). 98th International Conference of American Thoracic Society,2002 [A35] [poster:C68]. Available from:URL:http://www.thoracic.org/ic/ic2002
  • 8Kavuru MS,Sullivan EJ,Piccin R,et al. Exogenous granulocyte-macrophage colony-stimulating factor administration for pulmonary alveolar proteinosis. Am J Respir Crit Care Med,2000,161(4 Pt 1):1143-1148.
  • 9Seymour JF,Presneill JJ,Schoch OD,et al. Therapeutic efficacy of granulocyte-macrophage colony-stimulating factor in patients with idiopathic acquired alveolar proteinosis. Am J Respir Crit Care Med,2001,163:524-531.
  • 10Tanaka N,Watanabe J,Kitamura T,et al. Lungs of patients with idopathic pulmonary alveolar proteinosis express a factor which neutralizes granulocyte-macrophage colony stimulating factor. FEBS Lett,1999,442:246-250.

共引文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部